» Articles » PMID: 21687419

Vaccination with Human Induced Pluripotent Stem Cells Creates an Antigen-Specific Immune Response Against HIV-1 Gp160

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2011 Jun 21
PMID 21687419
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Induced pluripotent stem cells (iPSCs) are artificially derived from somatic cells that have been transduced with defined reprogramming factors. A previous report has indicated the possibility of using iPSCs as an immune stimulator to generate antigen-specific immunity. In our current study, we have investigated whether human iPSCs (hiPSCs) have the ability to enhance specific immune response against a human immunodeficiency virus type 1 (HIV-1) antigen in a xenogenic mouse model. Our results show that BALB/c mice immunized with hiPSCs transduced with an adenoviral vector encoding HIV-1 gp160 exhibited prominent antigen-specific cellular immune responses. We further found that pre-treatment of hiPSCs with ionizing radiation promotes the secretion of pro-inflammatory cytokines such as interleukin-1 alpha (IL-1α), IL-12, and IL-18. These cytokines might promote the activation of antigen-presenting cells and the effective induction of cellular immunity. Our present findings thus demonstrate that a hiPSCs-based vaccine has the potential to generate cellular immunity against viral antigens such as HIV-1 gp160 in a xenogenic condition.

Citing Articles

Evaluation of the safety and efficiency of cytotoxic T cell therapy sensitized by tumor antigens original from T-ALL-iPSC in vivo.

Li W, Zhou M, Wang L, Huang L, Chen X, Sun X Cancer Innov. 2024; 3(1):e95.

PMID: 38948536 PMC: 11212296. DOI: 10.1002/cai2.95.


Modelling human disease with pluripotent stem cells.

Siller R, Greenhough S, Park I, Sullivan G Curr Gene Ther. 2013; 13(2):99-110.

PMID: 23444871 PMC: 3785403. DOI: 10.2174/1566523211313020004.


Human-induced pluripotent stem cells: in quest of clinical applications.

Madonna R Mol Biotechnol. 2012; 52(2):193-203.

PMID: 22302314 DOI: 10.1007/s12033-012-9504-0.

References
1.
Weber A, Wasiliew P, Kracht M . Interleukin-1 (IL-1) pathway. Sci Signal. 2010; 3(105):cm1. DOI: 10.1126/scisignal.3105cm1. View

2.
Lieber A, He C, Kirillova I, Kay M . Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo. J Virol. 1996; 70(12):8944-60. PMC: 190992. DOI: 10.1128/JVI.70.12.8944-8960.1996. View

3.
Maitra B, Szekely E, Gjini K, Laughlin M, Dennis J, Haynesworth S . Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant. 2004; 33(6):597-604. DOI: 10.1038/sj.bmt.1704400. View

4.
Senju S, Haruta M, Matsunaga Y, Fukushima S, Ikeda T, Takahashi K . Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells. Stem Cells. 2009; 27(5):1021-31. DOI: 10.1002/stem.33. View

5.
Yamamoto H, Matano T . Anti-HIV adaptive immunity: determinants for viral persistence. Rev Med Virol. 2008; 18(5):293-303. DOI: 10.1002/rmv.577. View